Region:Global
Product Code:GDME0589EPD
Cardiac Valve Repairs-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Cardiac Valve Repairs-Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiac Valve Repairs currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Valve Repairs pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Cardiac Valve Repairs under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Valve Repairs and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Valve Repairs under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Abbott Vascular Inc
Admedus Ltd
Ample Medical Inc
Ancora Heart Inc
BioStable Science & Engineering, Inc.
Cardiosolutions Inc
Celyad SA
Children's Hospital Boston
CollPlant Ltd
CoreMedic AG
Coroneo Inc.
CUBE SRL
Daidalos Solutions BV
Edwards Lifesciences Corp
Emory University
Georgia Institute of Technology
Hangzhou DeJin Medtech Co Ltd
Kephalios SAS
Lartim Medical Ltd
Mardil Medical, Inc.
Mayo Clinic
Medtentia International Ltd Oy
MiCardia Corp
Michigan Critical Care Consultants, Inc.
Micro Interventional Devices, Inc.
Millipede LLC
Mitralix Ltd.
Mitre Medical Corp
Neochord Inc
Rambam Health Care Campus
ReCor Medical Inc
Strait Access Technologies (Pty) Ltd
Symetis SA
TransCardiac Therapeutics, LLC
TTK Healthcare Ltd
University of Manitoba
Valcare Medical
Valtech Cardio Ltd
Viacor Inc
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Cardiac Valve Repairs Overview 9
3 Products under Development 10
3.1 Cardiac Valve Repairs-Pipeline Products by Stage of Development 10
3.2 Cardiac Valve Repairs-Pipeline Products by Segment 11
3.3 Cardiac Valve Repairs-Pipeline Products by Territory 12
3.4 Cardiac Valve Repairs-Pipeline Products by Regulatory Path 13
3.5 Cardiac Valve Repairs-Pipeline Products by Estimated Approval Date 14
3.6 Cardiac Valve Repairs-Ongoing Clinical Trials 15
4 Cardiac Valve Repairs-Pipeline Products under Development by Companies 16
4.1 Cardiac Valve Repairs Companies-Pipeline Products by Stage of Development 16
4.2 Cardiac Valve Repairs-Pipeline Products by Stage of Development 18
5 Cardiac Valve Repairs Companies and Product Overview 20
5.1 Abbott Vascular Inc Company Overview 20
5.2 Admedus Ltd Company Overview 23
5.3 Ample Medical Inc Company Overview 24
5.4 Ancora Heart Inc Company Overview 25
5.5 BioStable Science & Engineering, Inc. Company Overview 28
5.6 Cardiosolutions Inc Company Overview 29
5.7 Celyad SA Company Overview 30
5.8 Children's Hospital Boston Company Overview 32
5.9 CollPlant Ltd Company Overview 34
5.10 CoreMedic AG Company Overview 35
5.11 Coroneo Inc. Company Overview 38
5.12 CUBE SRL Company Overview 39
5.13 Daidalos Solutions BV Company Overview 40
5.14 Edwards Lifesciences Corp Company Overview 42
5.15 Emory University Company Overview 46
5.16 Georgia Institute of Technology Company Overview 47
5.17 Hangzhou DeJin Medtech Co Ltd Company Overview 48
5.18 Kephalios SAS Company Overview 49
5.19 Lartim Medical Ltd Company Overview 50
5.20 Mardil Medical, Inc. Company Overview 51
5.21 Mayo Clinic Company Overview 54
5.22 Medtentia International Ltd Oy Company Overview 55
5.23 MiCardia Corp Company Overview 56
5.24 Michigan Critical Care Consultants, Inc. Company Overview 57
5.25 Micro Interventional Devices, Inc. Company Overview 59
5.26 Millipede LLC Company Overview 63
5.27 Mitralix Ltd. Company Overview 66
5.28 Mitre Medical Corp Company Overview 67
5.29 Neochord Inc Company Overview 69
5.30 Rambam Health Care Campus Company Overview 73
5.31 ReCor Medical Inc Company Overview 74
5.32 Strait Access Technologies (Pty) Ltd Company Overview 75
5.33 Symetis SA Company Overview 76
5.34 TransCardiac Therapeutics, LLC Company Overview 77
5.35 TTK Healthcare Ltd Company Overview 78
5.36 University of Manitoba Company Overview 79
5.37 Valcare Medical Company Overview 80
5.38 Valtech Cardio Ltd Company Overview 84
5.39 Viacor Inc Company Overview 91
6 Cardiac Valve Repairs- Recent Developments 92
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 92
6.2 May 24, 2018: CollPlant Announces First Quarter 2018 Financial Results 94
6.3 May 21, 2018: Edwards Announces Key Events For EuroPCR 2018 96
6.4 May 16, 2018: First patient treated in First-in-Man study of CoreMedic's ChordArt mitral valve repair system 97
6.5 May 14, 2018: Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair 97
6.6 May 08, 2018: Corindus Announces First Quarter 2018 Financial Results 98
6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 99
6.8 May 02, 2018: Solvay's tough, biocompatible Radel PPSU selected for valve sizers in BioStable Science & Engineering's HAART 300 aortic annuloplasty kit 99
6.9 Apr 30, 2018: Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy 100
6.10 Apr 30, 2018: Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures 101
6.11 Apr 25, 2018: Minimally Invasive Investigational Procedure Treats Mitral Regurgitation as an Alternative to Open Heart Surgery 101
6.12 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 102
6.13 Apr 12, 2018: CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer 104
6.14 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 104
6.15 Mar 29, 2018: Northwestern Memorial Hospital Surgeon First in Illinois to Repair Aortic Valve with Novel Ring 105
6.16 Mar 21, 2018: CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update 106
6.17 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 107
6.18 Feb 22, 2018: Tricuspid Valve Repair Company 4Tech Appoints Tom Fleming as President and CEO, and Dr. Keith Dawkins as CMO 108
6.19 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 109
6.20 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 111
6.21 Jan 29, 2018: Mardil Medical Appoints Martin Madden to Board of Directors 111
6.22 Jan 18, 2018: KEPHALIOS reports first patient implanted with Kalios, its breakthrough mitral valve repair device 112
6.23 Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 113
6.24 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 113
6.25 Dec 08, 2017: HighLife Names Former Biosensors CEO as Chairman of the Board 114
6.26 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 115
6.27 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 116
6.28 Nov 09, 2017: Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results 119
6.29 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 120
6.30 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 121
6.31 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 122
6.32 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 123
6.33 Oct 23, 2017: Micro Interventional Devices Continues Clinical Success of MIA Technology 125
6.34 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 126
6.35 Oct 05, 2017: Dextera Surgical Provides Corporate Update 127
6.36 Sep 26, 2017: BioStable Science & Engineering Announces the First Commercial Use of the HAART 200 Aortic Annuloplasty Device 127
6.37 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 128
6.38 Sep 18, 2017: Cardiosolutions Key US Patent Application for Adjustable Spacer Technology to Treat Heart Valve Regurgitation Receives Notice of Allowance 128
6.39 Sep 07, 2017: Micro Interventional Devices Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA Technology 129
6.40 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 130
6.41 Aug 15, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 200 Aortic Annuloplasty Device for Bicuspid Aortic Valve Repair 133
6.42 Aug 09, 2017: Abbott Leads Way In First Clinical Trial Of Minimally Invasive Clip-Based Repair System For Leaky Tricuspid Heart Valves 133
6.43 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 134
6.44 Aug 08, 2017: Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results 135
6.45 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 136
6.46 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 136
6.47 Jul 24, 2017: Millipede, Announces First Cases with 50mm Transcatheter Annuloplasty Ring Expanding Treatable Patient Population 138
6.48 Jul 18, 2017: Karolinska Institutet: Fewer infections in mechanical heart valves 138
6.49 Jul 10, 2017: Andrew ElBardissi, M.D. Named to NeoChord Board of Directors 139
6.50 Jun 14, 2017: BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART 300 Aortic Annuloplasty Device 140
7 Appendix 141
7.1 Methodology 141
7.2 About GlobalData 144
7.3 Contact Us 144
7.4 Disclaimer 144
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.